| Paringa Resources (NASDAQ: PNRL) Increases Coal Productivity Rate and Plant Yield |
| |
|
Paringa Resources (NASDAQ: PNRL) operates the low cost, high quality Poplar Grove Mine, part of the Buck Creek Complex located in the Illinois Coal Basin in western Kentucky. In the latest update of its underground coal mining operation, Paringa announced significant increases in productivity rates from its first production unit. Processing and surface operations are functioning well, and plant yield is increasing as out of seam dilution decreases.
Why It Matters: Western Kentucky is one of the world's best mining jurisdictions due to its access to low cost power, utilities, transportation and non-union labor pool. Mining conditions at Poplar Grove are similar to those encountered in neighboring mines, which rank as some of the most productive room-and-pillar operations in the world. Paringa’s Buck Creek Complex includes two fully permitted thermal coal mines: (1) the operating Poplar Grove Mine with production capacity ramping up to 2.8 Mtpa; and (2) the permitted Cypress Mine with planned production capacity of 3.8 Mtpa. Construction of the Poplar Grove Mine has been completed and production ramp-up has begun, with full production capacity targeted in 2020. The Company also has plans to develop the Cypress Mine.
What’s Next: In the coming months, Paringa will seek approval from the Mine Safety and Health Administration for an extended cut plan, with the potential for cut depths to be significantly increased from the current 20 ft limit. This approval, coupled with split ventilation, will enable another major step-change in mining productivity. All other surrounding mines in the region have received MSHA extended cut approval, with customary approval limits of up to 40 ft.
|
|
| |
|
| Expanded Retail Licenses Add New Growth Potential to Emerald Health Therapeutics (OTCQX: EMHTF) |
| |
|
The Government of Ontario announced plans to expand the province’s brick-and-mortar retail sales network for adult-use cannabis, an initiative that positions the industry and Emerald Health Therapeutics (OTCQX: EMHTF) for significant sales growth in Canada’s largest province.
Key Quote: “After the first 25 stores began to open in Ontario, the industry saw overall sales of cannabis basically double. Adult-use consumers are showing a preference for going into a physical location where they can interact with educated, savvy budtenders and we anticipate that the further expansion of physical stores in Ontario and Canada will strongly serve the growth of legal cannabis sales.” – Dr. Avtar Dhillon, Executive Chairman & President
What’s Next: In conjunction with Ontario’s retail expansion and in response to the Ontario Cannabis Store’s (OCS) most recent product call, Emerald has submitted its high-THC Island Honey, Critical Kali Mist and White Rhino premium strains of dried flower as well as its whole flower high-CBD Sync 25 oil. These Emerald products would further diversify Ontario shoppers’ available product choices.
|
|
| |
|
| Small Caps Continue to Lag Larger Cap Stocks |
| |
|
The broader market for small-cap stocks continues to lag its larger cap peers.
For the year to date, the benchmark Russell 2000 index is up nearly 17%, yet remains more than 8% below its record highs reached in August 2018. The large-cap S&P 500, by comparison, hit record highs last as part of its nearly 18.5% rally this year.
While some companies face the risk of compressed margins from lower interest rates and increased governmental regulation if Democrats win either the presidency or the Senate in the 2020 elections, smaller stocks with above average growth prospects continue to provide opportunity.
|
|
| |
|
| Digital Ally (NASDAQ: DGLY) Added to FTSE Russell Microcap® Index |
| |
|
Digital Ally (NASDAQ: DGLY), which develops, manufactures and markets advanced digital technology products for law enforcement, homeland security and commercial security applications, announced that it was added to the FTSE Russell Microcap® index yesterday at the conclusion of the 2019 FTSE Russell annual index reconstitution, effective July 1.
Key Quote: “We are very pleased for Digital Ally to have been added to the FTSE Russell Microcap® index, the increased exposure, recognition, and credibility of being part of the leading microcap index comes at an ideal time as we continue to make strides in expanding our business in established markets like law enforcement and in newer lines including commercial and consumer applications,” — Stan Ross, CEO of Digital Ally
The Backstory: Digital Ally, headquartered in Lenexa, KS, specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets, and consumer use. Digital Ally’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide.
Disclosure
Digital Ally, Inc. (NASDAQ: DGLY) is a client of RedChip Companies, Inc. DGLY agreed to pay RedChip Companies, Inc., a monthly cash fee for four (4) months of RedChip investor awareness services.
|
|
| |
|
| Bellicum Pharmaceuticals (NASDAQ: BLCM) Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial |
| |
|
Bellicum Pharmaceuticals (NASDAQ: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, announced that the primary endpoint of event free survival at 180 days in its BP-004 European registration trial for rivo-cel (rivogenlecleucel) has been achieved. Data from this trial will form the basis of an anticipated submission of European Marketing Authorisation Applications (MAAs) for rivo-cel and rimiducid in support of potential regulatory approval.
Key Quote: “These final results support our belief that rivo-cel, if approved, may be a transformational new treatment option for pediatric patients with leukemias, lymphomas and genetic blood diseases.” — Rick Fair, President & CEO of Bellicum Pharmaceuticals
The Backstory: Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company’s next-generation product candidates are differentiated by powerful cell signaling technologies designed to produce more effective CAR-T and allogeneic T cell therapies. Bellicum’s lead GoCAR-T® candidate, BPX-601, is designed to be a more efficacious CAR-T cell product capable of overriding key immune inhibitory mechanisms. Bellicum’s rivo-cel product candidate is an allogeneic polyclonal T cell therapy that has shown promising clinical trial results in reducing leukemia relapse after a stem cell transplant. More information can be found at www.bellicum.com.
|
|
| |
|
| |
| Quote of the Week |
| |
"You’ve got to make a decision to devote a decade of your life to something. It takes 10 years of your life to accomplish anything."
- Manny Villafana, CEO Kips Bay Medical |
|
|
|
|
|
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures. |
|
| |
|
|
| |
|
|
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
|
|
|
